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EFFECT OF PROBIOTIC-PREBIOTIC SUPPLEMENTATION WITH DIET
COUNSELING IN CHRONIC KIDNEY DISEASE
Manish Rathi, Nancy Sahni, HS Kohli, Vivekanand Jha, Vinay Sakhuja
Post Graduate Institute of Medical Education and Research, Chandigarh, India
Chronic kidney disease (CKD) is a progressive disease leading to
requirement of renal replacement therapy (RRT) over a period of time.
Limited availability and high cost of RRT in many countries necessitates the
researchers to focus on either prevention or slowing the progression of
CKD. High dose probiotics have been hypothesized to metabolize the
nitrogenous waste products, thus delaying the requirement of dialysis. The
purpose of this short term intervention study was to study the effect of
probiotic-prebiotic therapy and diet counseling on nutrition, renal
progression, and overall health of CKD patients. Thirty predialysis CKD
patients (21 males, 9 females) were included in the study. The diet charts
were designed according to the underlying nutritional status and blood
parameters. Calorie intake was 30-40 kcal/kg; proteins 0.6-0.8 g/kg (with
at least 50% high biological value); potassium 1.5-2 gm./day; and
phosphorus o1 gm./day. All patients were prescribed enteric coated
gelatin capsules containing lyophilized Streptococcus Thermophilus,
Lactobacillus Acidophilus, and Biﬁdobacterium Longum, in a dose of 15
billion colony forming units along with 100 mg Lactitol monohydrate as
prebiotic. Each patient received two capsules three times a day with each
meal. The mean age was 45 years (range 18-68). The statistical analysis
was done using ‘RGui’ software version 2.13.0 and the outcomes were
tested using paired t-test at 5% level of signiﬁcance. The mean calorie
intake increased from 1479 kcal/day to 1869 kcal/day (po0.0005), with
signiﬁcant reduction in protein, phosphorus and potassium intake. There
was signiﬁcant improvement in body mass index (p¼0.002) and serum
albumin levels (p¼0.005). All but four patients showed improvement or
stabilisation of glomerular ﬁltration rate (GFR), and the mean GFR
improved from 24.72 ml/min to 27.73 ml/min (p¼0.03). There was also
signiﬁcant improvement in triglyceride and LDL cholesterol levels. Twenty
ﬁve patients showed improvement in ﬁve point quality of life visual
analogue score, while no patient reported any signiﬁcant adverse event. In
conclusion, this short term study of diet counselling with probiotic
supplementation showed signiﬁcant improvement in various parameters
of CKD necessitating a longer term study.
http://dx.doi.org/10.1016/j.krcp.2012.04.526203
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Protein-energy wasting (PEW), reﬂected by serum albumin o4.0 g/dL, is
common in maintenance hemodialysis (MHD) patients (pts) and is associated
with poor outcomes.
Hyperphosphatemia (phosphorus 45.5 mg/dL) is also common and is
associated with high death risk. The traditional dietary approach to control
hyperphosphatemia by limiting protein foods may cause or worsen PEW. We
hypothesized that provision of a high protein diet including during HD
treatment results in favorable outcomes if a potent phosphorus binder such as
lanthanum carbonate (FosrenolTM) can control phosphorus simultaneously and
conducted a pilot/feasibility randomized controlled trial in 110
hypoalbuminemic (o4.0 mg/dL) MHD patients in several dialysis clinics. After
a washout period and upon 1:1 randomization, we provided the
INTERVENTION group with 8 weeks of high protein meals as prepared meal
boxes (50 g protein, 850 Cal, phosphorus to protein ratio o10mg/gm) during
each HD treatment, along with 0.5 to 1.5 g Fosrenol (titrated as needed) plus
dietary counseling to maintain a high dietary protein intake at home. The
CONTROL group received meal boxes containing low calorie (o50 Cal) and
almost no protein (o1 g, such as salads) during each HD treatment and
continued non-Fosrenol binders. We examined combined change in serum
albumin with remaining in target phosphorus range of 3.5-o5.5 mg/dL over
the 8 weeks of intervention. Among the 51 intervention and 55 control subjects
who qualiﬁed for the intention-to-treat analyses, the combined rise in albumin
Z0.2 g/dL while maintaining phosphorus in 3.5-o5.5 mg/dL range was
achieved in 25.5% and 9.8%, respectively (w2 p-value 0.036). No serious adverse
events were reported, and patients reported satisfaction with high proteinmeals during HD. Hence, provision of high protein meals combined with
FosrenolTM during HD is safe and may improve albumin while controlling
serum phosphorus. ClinicalTrials.gov # NCT0111694
http://dx.doi.org/10.1016/j.krcp.2012.04.527204
HAND GRIP STRENGTH AS A NUTRITIONAL MARKER IN PD AND
HEMODIALYSIS PATIENTS
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This is a prospective study evaluating hand grip strength as a nutritional
marker in maintenance dialysis patients. Thirty CAPD and 50 MHD patients
were assessed for hand grip strength (in the non-ﬁstula arm) and demographic
variables. In the MHD, 60% diabetic and in PD 66.7% were diabetic. In the MHD
patients, Mean Age - 53.62712.45, 78% Males and 22% Females, Hb-
9.771.1 g/dL and 3.8672.83 years on dialysis and in PD patients, mean age -
58.6711.52 , 63.3% males and 26.7% females, Hb – 10.571.4 g/dL and
3.3372.6 mean years on dialysis. Hand Grip Strength was 11.58þ3.7 kg pre-
dialysis and 9.2þ3.6 kg post dialysis in MHD and 10.8þ2.9 kg in PD patients.
We found that malnutrition was present in 90% of MHD (10% severe, 24%
moderate, 56% mild) and 100% (6.7% severe, 40% moderate, 53.3% mild) of PD
patients via hand grip comparison. In conclusion, hand grip strength is a simple
tool to measure the muscle mass as a measure of malnutrition in dialysis
patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.528205
RETROSPECTIVE ANALYSIS OF PATIENT SURVIVAL BASED ON
NUTRITIONAL STATUS IN A COHORT OF HEMODIALYSIS PATIENTS FROM
TWO LARGE CENTERS IN A METROPOLITAN CITY IN A
DEVELOPING COUNTRY
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This is a retrospective analysis of 858 patients from 2 medical centers on
maintenance hemodialysis from January 1998 - January 2010(Males–599,
females 259) (364 diabetics [42.5%]) (Mean Age - 48.5þ22.74, 460 - 76.5%
and o60 – 23.5%) (Vegetarians – 18.25%, Non-Vegetarians–81.75%).
Patients were followed up for 3 years. Demographic, nutritional and renal
parameters were documented. Mean albumin - 3.47þ0.67 g/dL, mean Hb -
8.56þ5.75 g/L, Serum calcium (corrected) - 8.6þ0.9 mg/dL, serum
phosphorus - 5.32þ1.85 mg/dL, mean Ca*Po4 product - 43.27þ17.62 mg2/
dL2, mean iPTH - 260.3þ295.3pg/mL, 25-OH D3 - 23.3þ20.2 mg/dL.
Overall, 191 patients died (22%) with an 86% and 78% patient survival at
1 year and 3 years.Age Hb
(g/L)Cor Ca.
(mg/dL)Albumin
(g/L)Ca*PO4
(mg/dL)25-OH D3
(mg/dL)Z60 9.077.9 8.670.9 3.570.6 42.6716.7 22.9718.7
o60 8.474.7 8.471.1 3.670.5 45.3720 24.5724.8
p value .550 .2660 .396 .235 .687There is no statistically signiﬁcant association between age, albumin levels,
vegetarianism with mortality.
http://dx.doi.org/10.1016/j.krcp.2012.04.529206
NUTRITIONAL ASSESSMENT OF CAPD PATIENTS
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Appearance and progressive development of malnutrition signiﬁcantly
inﬂuence the efﬁcacy and treatment outcome in chronic renal failure (CRF)
patients receiving continuous ambulatory peritoneal dialysis (CAPD) therapy.
